Myeloid growth factors Journal Article

Authors: Crawford, J.; Allen, J.; Armitage, J.; Blayney, D. W.; Cataland, S. R.; Heaney, M. L.; Htoy, S.; Hudock, S.; Kloth, D. D.; Kuter, D. J.; Lyman, G. H.; McMahon, B.; Steensma, D. P.; Vadhan-Raj, S.; Westervelt, P.; Westmoreland, M.
Article Title: Myeloid growth factors
Keywords: cancer survival; overall survival; fludarabine; prednisone; mortality; neutropenia; review; cisplatin; doxorubicin; fluorouracil; cancer combination chemotherapy; drug efficacy; drug safety; liver dysfunction; alpha interferon; gemcitabine; paclitaxel; adjuvant therapy; cancer radiotherapy; chemotherapy; cytarabine; methotrexate; rituximab; follow up; antineoplastic agent; carboplatin; dacarbazine; unindexed drug; melanoma; quality of life; neutrophil count; breast cancer; bone marrow suppression; etoposide; myalgia; nccn clinical practice guidelines; cyclophosphamide; dexamethasone; vincristine; bone pain; retrospective study; bladder cancer; risk factor; ifosfamide; vinblastine; high risk patient; risk assessment; docetaxel; arthralgia; febrile neutropenia; fever; hospitalization; peripheral t cell lymphoma; disease severity; myelodysplastic syndrome; nonhodgkin lymphoma; kidney function; dosage schedule comparison; adjuvant chemotherapy; mitoxantrone; single drug dose; sepsis; stomach cancer; 5 aza 2' deoxycytidine; methylprednisolone; disease duration; drug toxicity; large cell lymphoma; kidney cancer; mesna; trastuzumab; recombinant granulocyte colony stimulating factor; risk reduction; esophagus cancer; mental health; mycosis; infection risk; alemtuzumab; drug use; thymocyte antibody; nccn guidelines; randomized controlled trial (topic); clinical trial (topic); phase 2 clinical trial (topic); meta analysis (topic); myeloid growth factors; systematic review (topic)
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 9
Issue: 8
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2011-08-01
Start Page: 914
End Page: 932
Language: English
PROVIDER: scopus
PUBMED: 21900221
Notes: --- - "Export Date: 3 October 2011" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Mark L Heaney
    94 Heaney